Scripps Faculty Wants President Out

Some faculty members of the Scripps Research Institute are wary of a possible merger with USC and would like to oust the organization’s president.

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, ELIFE SCIENCES PUBLICATIONS, LTDThe University of Southern California (USC) in Los Angeles and the Scripps Research Institute (TSRI) in La Jolla are discussing some form of partnership, and Scripps faculty members are not happy about it. U-T San Diego reported on Friday (July 4) that professors there have begun “an unprecedented faculty revolt” to oust Scripps’s president, Michael Marletta.

Last week, all of the institute’s department chairs and its dean sent a letter to the chair of the board of trustees expressing their lack of confidence in Marletta. At issue is a possible merger with or takeover by USC, which faculty members said they want dropped. Additionally, members have said that Marletta has not done enough to buoy Scripps’s sinking financial situation.

Marletta told U-T San Diego, “there are more than 250 faculty members at Scripps. It is impractical to involve every single one of them in a time-consuming and exhaustive review of options for the institute’s future.”

A partnership with USC may help the financially troubled TSRI, which is projecting a $21 million operating deficit this year. Peter Farrell, a Scripps trustee, said, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies